knowcompoundsleukotriene F4
Specimen compound organic compound, anion
Leukotriene F4
A leukotriene anion obtained by deprotonation of the three carboxy groups and protonation of the glutamyl α-amino group of leukotriene F4; major species at pH 7.3.”
- 01Protein4 statements
- 02Compound2 statements
- Short, toward it1
- Formula
- C28H42N2O8S2−
- Molar mass
- 566.717 g/mol
- ChEBI
- CHEBI:133618
- InChIKey
- PYSODLWHFWCFLV-VJBFNVCUSA-L
01 · the reference layer, drawn
What it is linked to
reference statements, inferred one hop away · no finding · no strength
Leukotriene F4
Reference statements drawn
6statements · 3 neighbours
no finding, so no strength
Show all 3 neighboursHide the 3 neighbours
- (5S,6R,7E,9E,11Z,14Z)-6-(L-cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid×2
- SLC22A10×1
- SLCO1B1×3
Keys
← → round a ring↑ ↓ out and inEnter selecte the outer ringf fit to view+ − zoomEsc clearclick a node to select it
02 · identity
Structure
- Charge
- -2
- 3D model
- None at PubChem
- SMILES
- CCCCC/C=CC/C=CC=CC=C[C@@H](SC[C@H](NC(=O)CC[C@H]([NH3+])C(=O)[O-])C(=O)[O-])[C@@H](O)CCCC(=O)[O-]
03 · reach
What it touches on the way
1 entity · assembled from reference reactions
- SLCO1B1Protein9 paths · 2 endpointsinferred
Where it reaches
1 region · transporter routes
- Liverdigestive1 routeinferred
What the reference databases state
6Reference statements
What the reference databases state
Evidence keyStatements
6 statements
- leukotriene F4 is converted to (5S,6R,7E,9E,11Z,14Z)-6-(L-cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acidCompoundHuman-GEM MAR08549Inferred only
- (5S,6R,7E,9E,11Z,14Z)-6-(L-cystein-S-yl)-5-hydroxyicosa-7,9,11,14-tetraenoic acid is converted to leukotriene F4CompoundHuman-GEM MAR08549Inferred only
- leukotriene F4 is transported by SLC22A10ProteinHuman-GEM MAR06256Inferred only
- leukotriene F4 is transported by SLCO1B1ProteinHuman-GEM MAR06157, MAR06158, MAR06159Inferred only
9Reactions
05 · the record
Other names
3 names
LTF4(2-) · LTF4(2−)
systematic · (5S,6R,7E,9E,11Z,14Z)-6-{[(2R)-2-{[(4S)-4-azaniumyl-4-carboxylatobutanoyl]amino}-2-carboxylatoethyl]sulfanyl}-5-hydroxyicosa-7,9,11,14-tetraenoate